Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-18 | New | $3,750,000 | $3,750,000 | Debt Only | 06b | SEC link |
| 2025-02-18 | Amended | $3,750,000 | $0 | Debt Only | 06b | SEC link |
| 2022-10-04 | New | $21,542,628 | $21,542,628 | Equity Only | 06b | SEC link |
| 2021-11-22 | New | $1,163,814 | $1,163,814 | Debt Only | 06b | SEC link |
| 2020-09-23 | Amended | $11,916,407 | $2,235,794 | Equity Only | 06b | SEC link |
| 2019-02-22 | Amended | $9,680,613 | $1,000,000 | Equity Only | 06b | SEC link |
| 2018-06-01 | New | $8,680,613 | $8,680,613 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Samuel Banks | Director |
| Samuel Dean Banks | Director |
| Ryan Egeland | Director |
| Bobby Helmedag | Director |
| Jeffrey Julkowski | Director, Promoter |
| Jeff Julkowski | Director |
| Douglas Kohrs | Director |
| John Santini | Director, Executive |
| Margo Shoup | Director |
| Anita Watkins | Director |
| Anita Wilson | Director |
| Raymond Wong | Director |
| Jeffrey Yurecko | Executive |